294 results on '"Brennan, G P"'
Search Results
2. Understanding scientists' communication challenges at the intersection of climate and agriculture.
3. Epigenetic regulation of HCN channels: a window into neuroplasticity?
4. Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica
5. Erratum to: Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica
6. Antibacterial activity of Allium sativum against multidrug-resistant Vibrio harveyi isolated from black gill–diseased Fenneropenaeus indicus
7. Disruption of vitellogenesis and spermatogenesis by triclabendazole (TCBZ) in a TCBZ-resistant isolate of Fasciola hepatica following incubation in vitro with a P-glycoprotein inhibitor
8. Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax)
9. Fasciola hepatica: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke
10. Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha
11. Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke
12. A scanning electron microscope study on the route of entry of clorsulon into the liver fluke, Fasciola hepatica
13. Ultrastructural observations on oral ingestion and trans-tegumental uptake of clorsulon by the liver fluke, Fasciola hepatica
14. Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro
15. Transmission electron microscope study of the ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo drug treatment with clorsulon
16. Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes
17. Fasciola hepatica: tegumental surface alterations following treatment in vivo and in vitro with nitroxynil (Trodax)
18. Increased susceptibility of a triclabendazole (TCBZ)-resistant isolate of Fasciola hepatica to TCBZ following co-incubation in vitro with the P-glycoprotein inhibitor, R(+)-verapamil
19. Fasciola gigantica: tegumental surface alterations following treatment in vitro with the sulphoxide metabolite of triclabendazole
20. Specificity of a coproantigen ELISA test for fasciolosis: lack of cross-reactivity with Paramphistomum cervi and Taenia hydatigena
21. Book reviews
22. High prevalence of primary aldosteronism in the Tayside hypertension clinic population
23. Ultrastructure of the surface structures and haptor of Empleurosoma pyriforme (Ancyrocephalinae; Monopisthocotylea: Monogenea) from the gills of the teleost fish Therapon jarbua
24. Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica
25. Potent and lasting seizure suppression by systemic delivery of antagomirs targeting miR-134 timed with blood-brain barrier disruption
26. A transmission electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica
27. Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole
28. Electron microscopical study to assess the in vitro effects of the synthetic trioxolane OZ78 against the liver fluke, Fasciola hepatica
29. Ultrastructural changes to the tegumental system and the gastrodermal cells in adult Fasciola hepatica following in vivo treatment with the experimental fasciolicide, compound alpha
30. A scanning electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica
31. Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica
32. Meticillin-resistant Staphylococcus aureus transmission among healthcare workers, patients and the environment in a large acute hospital under non-outbreak conditions investigated using whole-genome sequencing.
33. Physiological and morphological effects of genistein against the liver fluke, Fasciola hepatica
34. Ultrastructure of the surface structures and electron immunogold labeling of peptide immunoreactivity in the nervous system of Pseudothoracocotyla indica (Polyopisthocotylea: Monogenea)
35. Ultrastructure of the gut caecal epithelium of Pricea multae (Monogenea: Polyopisthocotylea)
36. Eukaryotic expression of recombinant Pso o 1, an allergen from Psoroptes ovis, and its localization in the mite
37. Molecular characterization, expression and localization of tropomyosin and paramyosin immunodominant allergens from sheep scab mites (Psoroptes ovis)
38. Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha
39. Fine structure of the anterior adhesive apparatus (head organs) of Bravohollisia gussevi Lim, 1995 (Monogenea: Ancyrocephalidae)
40. Ultrastructural localisation of FMRFamide- and pancreatic polypeptide-immunoreactivities within the central nervous system of the liver fluke,Fasciola hepatica (Trematoda, Digenea)
41. Irish endocrine society: Proceedings of the 17th annual general meeting of the irish endocrine society held in Dublin on november 6th and 7th 1992.
42. Electron immunogold labeling of regulatory peptide immunoreactivity in the nervous system ofMoniezia expansa (Cestoda: Cyclophyllidea)
43. Dietary fish oil augments nitric oxide production or release in patients with Type 2 (non-insulin-dependent) diabetes mellitus
44. Impaired endothelium-dependent and independent vasodilation in patients with Type 2 (non-insulin-dependent) diabetes mellitus
45. Neuropeptide F-immunoreactivity in the monogenean parasiteDiclidophora merlangi
46. Irish endocrine society: Proceedings of the 16th Annual General Meeting held at the Ulster Hospital, Dundonald on November 1/2,1991
47. Mupirocin-Resistant Methicillin-Resistant Staphylococcus aureus (MRSA) and Vascular Surgery.
48. Fasciola hepatica: surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole (‘Valbazen’)
49. Book review
50. Surface changes in adult Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.